FGA
BIIB icon

Fortis Group Advisors’s Biogen BIIB Stock Holding History

Fortis Group Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.24K Hold
15
– – ﹤0.01% 475
2026
Q1 		$2.75K Hold
15
– – ﹤0.01% 471
2025
Q4 		$2.64K Hold
15
– – ﹤0.01% 472
2025
Q3 		$2.1K Hold
15
– – ﹤0.01% 449
2025
Q2 		$1.88K Hold
15
– – ﹤0.01% 448
2025
Q1 		$2.05K Hold
15
– – ﹤0.01% 409
2024
Q4 		$2.29K Hold
15
– – ﹤0.01% 421
2024
Q3 		$2.91K Hold
15
– – ﹤0.01% 396
2024
Q2 		$3.48K Hold
15
– – ﹤0.01% 381
2024
Q1 		$3.23K Sell
15
-15
-50% -$3.51K ﹤0.01% 407
2023
Q4 		$7.76K Buy
30
+15
+100% +$3.68K ﹤0.01% 323
2023
Q3 		$3.85K Buy
+15
New +$4.01K ﹤0.01% 312
2020
Q3 		$4K Buy
+15
New +$4.18K ﹤0.01% 349

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fortis Group Advisors's BIIB Position: Q2 2026 in Review

Fortis Group Advisors held its Biogen (BIIB) position steady in Q2 2026 at 15 shares worth $3.24K. The position accounts for ﹤0.01% of the portfolio, ranked #475.

Fortis Group Advisors first reported a position in BIIB in Q3 2020 and has held it in 13 quarters since. The position peaked at $7.76K in Q4 2023. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Fortis Group Advisors held 15 shares of Biogen worth $3.24K as of Q2 2026.
  • Fortis Group Advisors left its Biogen share count unchanged in Q2 2026.
  • Biogen made up ﹤0.01% of Fortis Group Advisors's portfolio in Q2 2026, its #475 holding.
  • Fortis Group Advisors first reported a position in Biogen in Q3 2020 and has held it in 13 quarters since.
  • Fortis Group Advisors's Biogen position peaked at $7.76K in Q4 2023.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Fortis Group Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.